Furthermore, the immunofluorescent staining results showed that no CD20 positive cells were observed in xenograft tumors, indicating the elimination of LCSCs in tumor by the specifically targeting to LCSCs and highly therapeutic efficacy of the CD20-HSPI&Fe3O4@SiNPs. This evidence concerns the gene MS4A1 and neoplasm.